Novel regenerative strategies to enhance periodontal therapy outcome

Expert Opinion on Biological Therapy

Volumn 9, Issue 4, 2009, Pages 399-410

  Elangovan, Satheesh ^a,b   Srinivasan, Sreedevi ^c   Ayilavarapu, Srinivas ^d  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^b FORSYTH INSTITUTE   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d BOSTON UNIVERSITY   (United States)

Author keywords

Cell therapy; Gene therapy; Growth factors; Regeneration

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 12; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4; BONE MORPHOGENETIC PROTEIN 6; BONE MORPHOGENETIC PROTEIN 9; DEXAMETHASONE; ENAMEL MATRIX PROTEIN; EPIDERMAL GROWTH FACTOR; FATTY ACID DERIVATIVE; FIBROBLAST GROWTH FACTOR; GEM 21S; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFUSE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LIPOXIN A; MATRIX PROTEIN; OSTEOGENIC PROTEIN 1; PLASMID DNA; PLATELET DERIVED GROWTH FACTOR; RESOLVIN E1; SIMVASTATIN; SOMATOMEDIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR LMP 1; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR RECEPTOR; UNCLASSIFIED DRUG; VASCULOTROPIN;

ARTHRITIS; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE DEFECT; BONE REGENERATION; CHRONIC INFLAMMATION; CLINICAL TRIAL; DEVELOPMENTAL BIOLOGY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENTIATION; GENETIC TRANSFECTION; GINGIVA DISEASE; HUMAN; IMMUNOGENICITY; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PERIODONTAL DISEASE; PERIODONTITIS; PERIODONTIUM; POSTMENOPAUSE OSTEOPOROSIS; PROTEIN FUNCTION; REVIEW; RHEUMATOID ARTHRITIS; SINGLE DRUG DOSE; TISSUE ENGINEERING; TISSUE REGENERATION; TISSUE REPAIR; TREATMENT RESPONSE; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; WOUND HEALING;

ANIMALS; BONE REGENERATION; GENE THERAPY; GUIDED TISSUE REGENERATION, PERIODONTAL; HUMANS; PERIODONTAL DISEASES; TREATMENT OUTCOME;

EID: 67649250009     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712590902778423     Document Type: Review

References (125)

1. U.S. Public Health Service, National institute of dental research. Oral Health of United States Adults; National findings. Bethesda, MD: National institute of dental research. (1987) NIH publication number 87-2868
2. Petersen PE, Yamamoto T. Improving the global health of older people: the approach of the WHO global programme. Community Dent Oral Epidemiol 2005;33:81-92 (Pubitemid 41577044)
3. Miles DA, Thomas MV. Radiology for the periodontal examination. Periodontics medicine, surgery and implants. Mosby Incorporation, Inc. 2004;Chapter 9:154-155
4. Wang HL, Greenwell H, Fiorellini J, et al. Periodontal regeneration. J Periodontol 2005;76:1601-1622
5. Grzesik WJ, Narayanan AS. Cementum and periodontal wound healing and regeneration. Crit Rev Oral Biol Med 2002;13:474-484 (Pubitemid 36570021)
6. Taba M Jr, Jin Q, Sugai JV, Giannobile WV. Current concepts in periodontal bioengineering. Orthod Craniofac Res 2005;8:292-302
7. Buser D, Dula K, Hess D, et al. Localized ridge augmentation with autografts and barrier membranes. Periodontology 2000 1999;9:151-163
8. Reynolds MA, Aichelmann-Reidy ME, Branch-Mays GL, Gunsolley JC. The efficacy of bone replacement grafts in the treatment of periodontal osseous defects. A systematic review. Ann Periodontol 2003;8:227-265
9. Albertson KS, Medoff RJ, Mitsunaga MM. The use of periosteally vascularized autografts to augment the fixation of large segmental allografts. Clin Orthop Relat Res 1991;269:113-119
10. Shenaq SM. Reconstruction of complex cranial and craniofacial defects utilizing iliac crest-internal oblique microsurgical free flap. Microsurgery 1988;9:154-158 (Pubitemid 18212663)
11. Trombelli L, Kim CK, Zimmerman GJ, Wikesjo UM. Retrospective analysis of factors related to clinical outcome of guided tissue regeneration procedures in intrabony defects. J Clin Periodontol 1997;24:366-371 (Pubitemid 127731536)
12. Giannobile WV, Somerman MJ. Growth and amelogenin-like factors in periodontal wound healing. A systematic review. Ann Periodontol 2003;8:193-204
13. White AP, Vaccaro AR, Hall JA, et al. Clinical applications of BMP-7/OP-1 in fractures, nonunions and spinal fusion. Int Orthop 2007;31:735-741 (Pubitemid 350160312)
14. Garrison KR, Donell S, Ryder J, et al. Clinical effectiveness and cost-effectiveness of bone morphogenetic proteins in the non-healing of fractures and spinal fusion: a systematic review. Health Technol Assess 2007;11:1-150, iii-iv (Pubitemid 47484599)
15. Kwan MD, Slater BJ, Wan DC, Longaker MT. Cell-based therapies for skeletal regenerative medicine. Hum Mol Genet 2008;17:R93-98
16. American Academy of Periodontology position paper. Periodontal regeneration. J Periodontol 2005;76(9):1601-1622
17. Pitaru S, McCulloch CA, Narayanan SA. Cellular origins and differentiation control mechanisms during periodontal development and wound healing. J Periodontal Res 1994;29:81-94
18. Bartold PM, McCulloch CA, Narayanan AS, Pitaru S. Tissue engineering: a new paradigm for periodontal regeneration based on molecular and cell biology. Periodontology 2000;24:253-269
19. Iglhaut J, Aukhil I, Simpson DM, et al. Progenitor cell kinetics during guided tissue regeneration in experimental periodontal wounds. J Periodontal Res 1988;23(2):107-117
20. Cochran DL, Wozney JM. Biological mediators for periodontal regeneration. Periodontology 1999;19:40-58
21. Rutherford RB, Trailsmith MD, Ryan ME, Charette MF. Synergistic effects of dexamethasone on platelet-derived growth factor mitogenesis in vitro. Arch Oral Biol 1992;37:139-145
22. Howell TH, Fiorellini JP, Paquette DW, et al. A Phase I/II clinical trial to evaluate a combination of recombinant human platelet-derived growth factor-BB and recombinant human insulin-like growth factor-I in patients with periodontal disease. J Periodontol 1997;68:1186-1193 (Pubitemid 28041649)
23. Patel ZS, Young S, Tabata Y, et al. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. J Bone Miner Res 2008;20:848-857
24. Boyne PJ. Animal studies of application of rhBMP-2 in maxillofacial reconstruction. Bone 1996;19:83S-92S (Pubitemid 26254478)
25. Cochran DL, Schenk R, Buser D, et al. Recombinant human bone morphogenetic protein-2 stimulation of bone formation around endosseous dental implants. J Periodontol 1999;70:139-150
26. Wikesjo UM, Razi SS, Sigurdsson TJ, et al. Periodontal repair in dogs: effect of recombinant human transforming growth factor-beta1 on guided tissue regeneration. J Clin Periodontol 1998;25:475-481 (Pubitemid 128705296)
27. Giannobile WV, Hernandez RA, Finkelman RD, et al. Comparative effects of platelet-derived growth factor-BB and insulin-like growth factor-I, individually and in combination, on periodontal regeneration in Macaca fascicularis. J Periodont Res 1996;31:301-312 (Pubitemid 126104034)
28. Matsuda N, Kumar NM, Ramakrishnan PR, et al. Evidence for up-regulation of epidermal growth-factor receptors on rat periodontal ligament fibroblastic cells associated with stabilization of phenotype in vitro. Arch Oral Biol 1993;38:559-569 (Pubitemid 223068827)
29. Murakami S, Takayama S, Kitamura M, et al. Recombinant human basic fibroblast growth factor (bFGF) stimulates periodontal regeneration in class II furcation defects created in beagle dogs. J Periodont Res 2003;38:97-103 (Pubitemid 37463603)
30. Kohler N, Lipton A. Platelets as a source of fibroblast growth-promoting activity. Exp Cell Res 1974;87:297-301
31. Canalis E, McCarthy TL, Centrella M. Effects of platelet-derived growth factor on bone formation in vitro. J Cell Physiol 1989;140:530-537 (Pubitemid 19241771)
32. Strayhorn CL, Garrett JS, Dunn RL, et al. Growth factors regulate expression of osteoblast-associated genes. J Periodontol 1999;70:1345-1354
33. Gamal AY, Mailhot JM. The effect of local delivery of PDGF-BB on attachment of human periodontal ligament fibroblasts to periodontitis-affected root surfaces - in vitro. J Clin Periodontol 2000;27:347-353
34. Nevins M, Giannobile WV, McGuire MK, et al. Platelet-derived growth factor stimulates bone fill and rate of attachment level gain: results of a large multicenter randomized controlled trial. J Periodontol 2005;76:2205-2215 (Pubitemid 43116085)
35. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147 (Pubitemid 29282067)
36. Marx RE, Carlson ER, Eichstaedt RM, et al. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85(6):638-646 (Pubitemid 128641964)
37. Mott DA, Mailhot J, Cuenin MFM, et al. Enhancement of osteoblast proliferation in vitro by selective enrichment of demineralized freeze-dried bone allograft with specific growth factors. J Oral Implantol 2002;28:57-66
38. Giannobile WV, Whitson SW, Lynch SE. Non-coordinate control of bone formation displayed by growth factor combinations with IGF-I. J Dent Res 1997;76:1569-1578 (Pubitemid 127748950)
39. Murakami S, Takayama S, Ikezawa K, et al. Regeneration of periodontal tissues by basic fibroblast growth factor. J Periodont Res 1999;34:425-430
40. Nevins M. Hanratty J, Lynch SE: Clinical results using recombinant human platelet- derived growth factor and mineralized freeze-dried bone allograft in periodontal defects. Int J Periodontics Restorative Dent 2007;27(5):421-427
41. Urist MR. Bone: formation by autoinduction. Science 1965;150:893-899
42. Schmitz JP, Hollinger JO. The critical size defect as an experimental model for craniomandibulofacial nonunions. Clin Orthop Relat Res 1986;205:299-308 (Pubitemid 16011282)
43. Zhao M, Xiao G, Berry JE, et al. Bone morphogenetic protein 2 induces dental follicle cells to differentiate toward a cementoblast/osteoblast phenotype. J Bone Miner Res 2002;17:1441-1451 (Pubitemid 34803828)
44. Ahn SH, Kim CS, Suk HJ, et al. Effect of recombinant human bone morphogenetic protein-4 with carriers in rat calvarial defects. J Periodontol 2003;74:787-797 (Pubitemid 36880728)
45. Heifetz S, Li IW, McCulloch CA, et al. Influence of osteogenic protein-1 (OP-1;BMP-7) and transforming growth factor-beta 1 on bone formation in vitro. Connect Tissue Res 1996;35(1-4):71 (Pubitemid 27118838)
46. Wikesjo UM, Sorensen RG, Kinoshita A, et al. Periodontal repair in dogs: effect of recombinant human bone morphogenetic protein-12 (rhBMP-12) on regeneration of alveolar bone and periodontal attachment. J Clin Periodontol 2004;31:662-670 (Pubitemid 39092230)
47. Fiorellini JP, Howell TH, Cochran D, et al. Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation. J Periodontol 2005;76(4):605-611 (Pubitemid 40711289)
48. Huang YC, Kaigler D, Rice KG, et al. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res 2005;20:848-857 (Pubitemid 40571642)
49. Hsiong SX, Mooney DJ. Regeneration of vascularized bone. Periodontology 2000 2006;41:109-122 (Pubitemid 43937567)
50. King GN, King N, Hughes FJ. Effect of two delivery systems for recombinant human bone morphogenetic protein-2 on periodontal regeneration in vivo. J Periodont Res 1998;33:226-236 (Pubitemid 128527150)
51. Talwar R, Di Silvio L, Hughes FJ, King GN. Effects of carrier release kinetics on bone morphogenetic protein-2-induced periodontal regeneration in vivo. J Clin Periodontol 2001;28:340-347 (Pubitemid 33761344)
52. Engler AJ, Sen S, Sweeney HL, Discher DE. Matrix elasticity directs stem cell lineage specification. Cell 2006;126(4):677-689
53. Shin H, Jo S, Mikos AG. Biomimetic materials for tissue engineering. Biomaterials 2003;24:4353-4364 (Pubitemid 36960133)
54. Papadopoulos CE, Dereka XE, Vavouraki EN, Vrotsos IA. In vitro evaluation of the mitogenic effect of platelet-derived growth factor-BB on human periodontal ligament cells cultured with various bone allografts. J Periodontol 2003;74:451-457
55. Nevins M, Camelo M, Nevins ML, et al. Periodontal regeneration in humans using recombinant human platelet-derived growth factor-BB (rhPDGF-BB) and allogenic bone. J Periodontol 2003;74:1282-1292 (Pubitemid 37336738)
56. Jin Q, Wei G, Lin Z, et al. Nanofibrous scaffolds incorporating PDGF-BB microspheres induce chemokine expression and tissue neogenesis in vivo. PLoS ONE 2008;3:e1729. Published online March 5, 2008 doi:10.1371/journal.pone.0001729 (Pubitemid 351903228)
57. Cooke JW, Sarment DP, Whitesman LA, et al. Effect of rhPDGF-BB delivery on mediators of periodontal wound repair. Tissue Eng 2006;12:1441-1450 (Pubitemid 44174780)
58. Margolis HC, Beniash E, Fowler CE. Role of macromolecular assembly of enamel matrix proteins in enamel formation. J Dent Res 2006;85:775-793 (Pubitemid 44409025)
59. Bosshardt DD. Biological mediators and periodontal regeneration: a review of enamel matrix proteins at the cellular and molecular levels. J Clin Periodontol 2008;35:87-105
60. Hatakeyama J, Sreenath T, Hatakeyama Y, et al. The receptor activator of nuclear factor-κB ligand-mediated osteoclastogenic pathway is elevated in amelogenin-null mice. J Biol Chem 2003;278:35743-35748 (Pubitemid 37102350)
61. Mundy G, Garrett R, Harris S, et al. Stimulation of bone formation in vitro and in rodents by statins. Science 1999;286(5446):1946-1949 (Pubitemid 129515901)
62. Alam S, Ueki K, Nakagawa K, et al. Statin-induced bone morphogenetic protein (BMP) 2 expression during bone regeneration: an immunohistochemical study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009;107:22-29
63. Thylin MR, McConnell JC, Schmid MJ, et al. Effects of simvastatin gels on murine calvarial bone. J Periodontol 2002;73(10):1141-1148 (Pubitemid 35256265)
64. Seto H, Ohba H, Tokunaga K, et al. Topical administration of simvastatin recovers alveolar bone loss in rats. J Periodont Res 2008;43(3):261-267
65. Yazawa H, Zimmermann B, Asami Y, Bernimoulin JP. Simvastatin promotes cell metabolism, proliferation, and osteoblastic differentiation in human periodontal ligament cells. J Periodontol 2008;76(2):295-302
66. Cunha-Cruz J, Saver B, Maupome G, Hujoel PP. Statin use and tooth loss in chronic periodontitis patients. J Periodontol 2006;77(6):1061-1066 (Pubitemid 44740623)
67. Vaziri H, Naserhojjati-Roodsari R, Tahsili-Fahadan N, et al. Effect of simvastatin administration on periodontitis-associated bone loss in ovariectomized rats. J Periodontol 2007;78(8):1561-1567
68. Baltzer AW, Lieberman JR. Regional gene therapy to enhance bone repair. Gene Ther 2004;11:344-350 (Pubitemid 38263084)
69. Evans CH, Gouze JN, Gouze E, et al. Osteoarthritis gene therapy. Gene Ther 2004;11:379-389 (Pubitemid 38263088)
70. Breitbart AS, Grande DA, Mason JM, et al. Gene-enhanced tissue engineering: applications for bone healing using cultured periosteal cells transduced retrovirally with the BMP-7 gene. Ann Plast Surg 1999;42:488-495 (Pubitemid 29218313)
71. Engstrand T, Daluiski A, Bahamonde ME, et al. Transient production of bone morphogenetic protein 2 by allogeneic transplanted transduced cells induces bone formation. Hum Gene Ther 2000;11:205-211 (Pubitemid 30044052)
72. Musgrave DS, Pruchnic R, Wright V, et al. The effect of bone morphogenetic protein-2 expression on the early fate of skeletal muscle-derived cells. Bone 2001;28:499-506 (Pubitemid 32410001)
73. Cheng H, Jiang W, Phillips FM, et al. Osteogenic activity of the fourteen types of human bone morphogenetic proteins (BMPs). J Bone Joint Surg 2003;85-A:1544-1552 (Pubitemid 36951140)
74. Li JZ, Li H, Sasaki T, et al. Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat. Gene Ther 2003;10:1735-1743 (Pubitemid 37121045)
75. Giannobile WV, Lee CS, Tomala MP, et al. Platelet-derived growth factor (PDGF) gene delivery for application in periodontal tissue engineering. J Periodontol 2001;72(6):815-823 (Pubitemid 33606564)
76. Jin Q, Anusaksathien O, Webb SA, et al. Engineering of tooth-supporting structures by delivery of PDGF gene therapy vectors. Mol Ther 2004;9(4):519-526 (Pubitemid 38578802)
77. Jin QM, Anusaksathien O, Webb SA, et al. Gene therapy of bone morphogenetic protein for periodontal tissue engineering. J Periodontol 2003;74:202-213 (Pubitemid 36322275)
78. Gouze E, Ghivizzani SC, Robbins PD, Evans CH. Gene therapy for rheumatoid arthritis. Curr Rheumatol Rep 2001;3:79-85
79. Yang S, Wei D, Wang D, et al. In vitro and in vivo synergistic interactions between the Runx2/Cbfa1 transcription factor and bone morphogenetic protein-2 in stimulating osteoblast differentiation. J Bone Miner Res 2003;18:705-715
80. Zhao Z, Zhao M, Xiao G, Franceschi RT. Gene transfer of the Runx2 transcription factor enhances osteogenic activity of bone marrow stromal cells in vitro and in vivo. Mol Ther 2005;12:247-253 (Pubitemid 41025094)
81. Franceschi RT. Biological approaches to bone regeneration by gene therapy. J Dent Res 2005;84(12):1093-1103 (Pubitemid 43827776)
82. Koh JT, Zhao Z, Wang Z, et al. Combinatorial gene therapy with BMP2/7 enhances cranial bone regeneration. J Dent Res 2008;87:845-849
83. Luo D, Saltzman WM. Synthetic DNA delivery systems. Nat Biotechnol 2000;18:33-37 (Pubitemid 30041168)
84. Phillips JE, Gersbach CA, Garcia AJ. Virus-based gene therapy strategies for bone regeneration. Biomaterials 2007;28:211-229 (Pubitemid 44537380)
85. Hacein-Bey-Abina S, von Kalle C, Schmidt M, et al. A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2003;348:255-256 (Pubitemid 36077924)
86. Budker V, Budker T, Zhang G, et al. Hypothesis: naked plasmid DNA is taken up by cells in vivo by a receptor-mediated process. J Gene Med 2000;2(2):76-88
87. Oligino TJ, Yao Q, Ghivizzani SC, Robbins P. Vector systems for gene transfer to joints. Clin Orthop Relat Res 2000;379(Suppl):S17-30 (Pubitemid 30766109)
88. Orrantia E, Chang PL. Intracellular distribution of DNA internalized through calcium phosphate precipitation. Exp Cell Res 1990;190:170-174 (Pubitemid 20340913)
89. Sethuraman S, Nair LS, El-Amin S, et al. Novel low temperature setting nanocrystalline calcium phosphate cements for bone repair: osteoblast cellular response and gene expression studies. J Biomed Mater Res A 2007;82(4):884-891 (Pubitemid 47312903)
90. Ono I, Yamashita T, Jin HY, et al. Combination of porous hydroxyapatite and cationic liposomes as a vector for BMP-2 gene therapy. Biomaterials 2004;25(19):4709-4718 (Pubitemid 38561158)
91. Oda M, Kuroda S, Kondo H, Kasugai S. Hydroxyapatite fiber material with BMP-2 gene induces ectopic bone formation. J Biomed Mater Res B Appl Biomater 2008 [Epub ahead of print]
92. Endo M, Kuroda S, Kondo H, et al. Bone regeneration by modified gene-activated matrix: effectiveness in segmental tibial defects in rats. Tissue Eng 2006;12(3):489-497 (Pubitemid 43673454)
93. Zhang Y, Wang Y, Shi B, Cheng X. A platelet-derived growth factor releasing chitosan/coral composite scaffold for periodontal tissue engineering. Biomaterials 2007;28(8):1515-1522 (Pubitemid 46027254)
94. Gazit D, Turgeman G, Kelley P, et al. Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: a novel cell-mediated gene therapy. J Gene Med 1999;1:121-133 (Pubitemid 129631069)
95. Moutsatsos IK, Turgeman G, Zhou S, et al. Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol Ther 2001;3:449-461 (Pubitemid 32509838)
96. Chen Y, Luk KD, Cheung KM, et al. Gene therapy for new bone formation using adeno-associated viral bone morphogenetic protein-2 vectors. Gene Ther 2003;10:1345-1353 (Pubitemid 36987125)
97. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-49 (Pubitemid 34742565)
98. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282(5391):1145-1147 (Pubitemid 28516247)
99. Frankel MS. In search of stem cell policy. Science 2000;287:1397
100. Bianco P, Robey PG. Stem cells in tissue engineering. Nature 2001;414:118-121 (Pubitemid 33041636)
101. Kadiyala S, Young RG, Thiede MA, Bruder SP. Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant 1997;6:125-134 (Pubitemid 27188295)
102. Bruder SP, Scadutto T. Bone Regeneration and Repair. Human press. NJ Page 2005:67-92
103. Haynesworth SE, Goshima J, Goldberg VM, Caplan AI. Characterization of cells with osteogenic potential from human marrow. Bone 1992;13:81-88
104. Connolly J, Guse R, Lippiello L, Dehne R. Development of an osteogenic bone-marrow preparation. J Bone Joint Surg 1989;71:684-691 (Pubitemid 19179655)
105. Connolly JF, Guse R, Tiedeman J, Dehne R. Autologous marrow injection as a substitute for operative grafting of tibial nonunions. Clin Orthop Relat Res 1991:259-270
106. Simmons CA, Alsberg E, Hsiong S, et al. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 2004;35:562-569 (Pubitemid 38953205)
107. Kawaguchi H, Hirachi A, Hasegawa N, et al. Enhancement of periodontal tissue regeneration by transplantation of bone marrow mesenchymal stem cells. J Periodontol 2004;75(9):1281-1287 (Pubitemid 39419730)
108. Seo BM, Miura M, Gronthos S, et al. Investigation of multipotent postnatal stem cells from human periodontal ligament. Lancet 2004;364:149-155 (Pubitemid 38891686)
109. Liu Y, Zheng Y, Ding G, et al. Periodontal ligament stem cell-mediated treatment for periodontitis in miniature swine. Stem Cells (Dayton, Ohio) 2008;26:1065-1073
110. Benatti BB, Silverio KG, Casati MZ, et al. Physiological features of periodontal regeneration and approaches for periodontal tissue engineering utilizing periodontal ligament cells. J Biosci Bioeng 2007;103:1-6 (Pubitemid 46216897)
111. American Academy of Periodontology. Position paper. The pathogenesis of periodontal diseases. J Periodontol 1999;70:457-470
112. Socransky SS, Haffajee AD, Cugini MA, et al. Microbial complexes in subgingival plaque. J Clin Periodontol 1998;25:134-144 (Pubitemid 128705944)
113. Deguchi S, Hori T, Creamer H, Gabler W. Neutrophil-mediated damage to human periodontal ligament-derived fibroblasts: role of lipopolysaccharide. J Periodont Res 1990;25:293-299 (Pubitemid 20329861)
114. Van Dyke TE, Zinney W, Winkel K, et al. Neutrophil function in localized juvenile periodontitis. Phagocytosis, superoxide production and specific granule release. J Periodontol 1986;57:703-708
115. Altman LC, Baker C, Fleckman P, et al. Neutrophil-mediated damage to human gingival epithelial cells. J Periodont Res 1992;27:70-79
116. Shapira L, Borinski R, Sela MN, Soskolne A. Superoxide formation and chemiluminescence of peripheral polymorphonuclear leukocytes in rapidly progressive periodontitis patients. J Clin Periodontol 1991;18:44-48
117. Hasturk H, Kantarci A, Goguet-Surmenian E, et al. Resolvin E1 regulates inflammation at the cellular and tissue level and restores tissue homeostasis in vivo. J Immunol 2007;179(10):7021-7029
118. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual antiinflammatory and pro-resolution lipid mediators. Nat Rev 2008;8:349-361 (Pubitemid 351595216)
119. Arita M, Bianchini F, Aliberti J, et al. Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J Exp Med 2005;201:713-722 (Pubitemid 40395117)
120. Serhan CN, Maddox JF, Petasis NA, et al. Design of lipoxin A4 stable analogs that block transmigration and adhesion of human neutrophils. Biochemistry 1995;34:14609-14615 (Pubitemid 3000720)
121. Papayianni A, Serhan CN, Brady HR. Lipoxin A4 and B4 inhibit leukotriene-stimulated interactions of human neutrophils and endothelial cells. J Immunol 1996;156:2264-2272 (Pubitemid 26087457)
122. Schwab JM, Chiang N, Arita M, Serhan CN. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 2007;447:869-874 (Pubitemid 46920139)
123. Serhan CN, Jain A, Marleau S, et al. Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol 2003;171(12):6856-6865 (Pubitemid 37532121)
124. Hasturk H, Kantarci A, Ohira T, et al. RvE1 protects from local inflammation and osteoclast-mediated bone destruction in periodontitis. FASEB J 2006;20(2):401-403 (Pubitemid 46671185)
125. Herrera BS, Ohira T, Gao L, et al. An endogenous regulator of inflammation, resolvin E1, modulates osteoclast differentiation and bone resorption. Br J Pharmacol 2008;155:1214-1223